Search Results

Showing results 21 - 30 of 1771.
Sort By: Date ▼

Inside CMS' plan to lower drug costs for Medicare Part D enrollees

November 28, 2018

CMS' proposed rule seeks to eliminate barriers that prevent Medicare Part D and Medicare Advantage enrollees from accessing lower-cost drugs by giving Part D plans more flexibility to use formulary management tools, such as prior authorizations and step therapy.

PrEP should be offered to all patients with high risk of HIV, USPSTF says in draft statement

November 26, 2018

The United States Preventive Services Task Force in a draft statement for the first time is recommending that health care providers offer pre-exposure prophylaxis (PrEP) with antiretroviral therapy to patients at high risk for HIV infection—which could make PrEP more accessible to patients.

How Geisinger Health Plan cut hepatitis C treatment costs by 20%—without sacrificing cure rate

November 26, 2018

The medical community celebrated when researchers developed a breakthrough therapy that could fully eliminate hepatitis C, but the treatment's $100,000 price tag prompted Geisinger Health Plan to craft a unique approach to reducing costs.

The 11 best-performing health care CEOs in the world, according to Harvard Business Review

November 21, 2018

Harvard Business Review's annual ranking of the 100 "Best-Performing CEOs in the World" includes 11 CEOs in the health care industry.

Grassley will chair Senate Finance Committee—and some say he'll crack down on pharma

November 21, 2018

Sen. Chuck Grassley (R-Iowa) will take over as chair of the Senate Finance Committee in January 2019, and some observers say the move could be bad news for the pharmaceutical industry.

Amid epidemic, opioid reversal drug saw a 600% price surge, Senate report finds

November 21, 2018

A report from the Senate's Permanent Subcommittee on Investigations found the price of EVZIO, a drug designed to reverse an opioid drug-related overdose, increased from $575 per unit in 2014 to $4,100 per unit in 2017.

How a new trial could offer hope for children with severe peanut allergies

November 20, 2018

Researchers have announced the results of a clinical trial that could lead to the first-ever FDA approval of an oral immunotherapy regimen to reduce children's allergic response to peanuts.

Pfizer to resume price increases in 2019

November 19, 2018

Pfizer says it plans to increase the list prices of 41 of its medical treatments in January, with price increases ranging from 3% to 9%.

In the states: California OKs CVS-Aetna merger, Michigan gets approval to negotiate Medicaid drug prices, and more

November 16, 2018

American Health Line rounds up the latest health care news in the states.

The 30 rising health care stars under 30, according to Forbes

November 15, 2018

Forbes this week released its annual 30 Under 30 in health care list, which includes biological researchers, entrepreneurs, physicians, and PhD students under 30 years of age who are working to improve health care delivery in the United States.

Results Page: [Previous] 1 2 3 4 5  ... [Next]